$MRTN
MARTEN TRANSPORT LTD

2024 Q1 Form 10-K Financial Statement

#000143774924005794 Filed on February 28, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $249.7M $268.2M $1.131B
YoY Change -16.22% -16.85% -10.48%
Cost Of Revenue $170.1M $181.3M $758.6M
YoY Change -14.68% -17.9% -11.66%
Gross Profit $79.54M $86.88M $372.9M
YoY Change -19.34% -14.57% -7.98%
Gross Profit Margin 31.86% 32.39% 32.95%
Selling, General & Admin $32.67M $36.56M $144.6M
YoY Change -10.13% 11.31% 14.64%
% of Gross Profit 41.08% 42.08% 38.79%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $28.53M $28.75M $116.7M
YoY Change -3.4% -2.96% 5.14%
% of Gross Profit 35.87% 33.09% 31.3%
Operating Expenses $68.46M $73.03M $296.4M
YoY Change -8.54% 1.61% 7.67%
Operating Profit $11.08M $13.86M $76.50M
YoY Change -53.38% -53.55% -41.14%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $796.0K $868.0K $3.806M
YoY Change -5.69% 66.92% 360.22%
Pretax Income $13.05M $16.52M $93.92M
YoY Change -56.3% -50.38% -34.86%
Income Tax $3.400M $4.126M $23.54M
% Of Pretax Income 26.06% 24.97% 25.07%
Net Earnings $9.646M $12.40M $70.37M
YoY Change -57.13% -51.4% -36.23%
Net Earnings / Revenue 3.86% 4.62% 6.22%
Basic Earnings Per Share $0.12 $0.87
Diluted Earnings Per Share $0.12 $0.15 $0.86
COMMON SHARES
Basic Shares Outstanding 81.32M 81.31M 81.27M
Diluted Shares Outstanding 81.44M 81.41M

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $73.73M $53.21M $53.21M
YoY Change -23.43% -33.98% -33.98%
Cash & Equivalents $73.73M $53.21M $53.21M
Short-Term Investments
Other Short-Term Assets $24.67M $27.51M $27.51M
YoY Change 1.9% 0.7% 0.7%
Inventory $6.286M
Prepaid Expenses
Receivables $105.2M $105.5M $105.5M
Other Receivables $10.38M $10.36M $10.36M
Total Short-Term Assets $214.0M $196.6M $196.6M
YoY Change -12.25% -16.65% -16.65%
LONG-TERM ASSETS
Property, Plant & Equipment $777.5M $792.2M $792.2M
YoY Change 5.97% 8.8% 8.8%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.499M $1.524M $1.524M
YoY Change -8.65% -8.85% -8.85%
Total Long-Term Assets $779.0M $793.8M $793.8M
YoY Change 5.93% 8.76% 8.76%
TOTAL ASSETS
Total Short-Term Assets $214.0M $196.6M $196.6M
Total Long-Term Assets $779.0M $793.8M $793.8M
Total Assets $993.0M $990.3M $990.3M
YoY Change 1.4% 2.55% 2.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $37.73M $36.52M $36.52M
YoY Change -9.22% -2.1% -2.1%
Accrued Expenses $29.42M $26.71M $26.71M
YoY Change 1.17% -35.27% -35.27%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $111.4M $110.2M $110.2M
YoY Change -6.82% -11.32% -11.32%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $202.0K $249.0K $249.0K
YoY Change -39.7% -39.12% -39.12%
Total Long-Term Liabilities $202.0K $249.0K $249.0K
YoY Change -39.7% -39.12% -39.12%
TOTAL LIABILITIES
Total Short-Term Liabilities $111.4M $110.2M $110.2M
Total Long-Term Liabilities $202.0K $249.0K $249.0K
Total Liabilities $230.6M $233.0M $233.0M
YoY Change -10.54% -11.01% -11.01%
SHAREHOLDERS EQUITY
Retained Earnings $711.5M $706.8M
YoY Change 5.64% 7.75%
Common Stock $50.88M $50.60M
YoY Change 6.08% 5.42%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $762.4M $757.4M $757.4M
YoY Change
Total Liabilities & Shareholders Equity $993.0M $990.3M $990.3M
YoY Change 1.4% 2.55% 2.55%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income $9.646M $12.40M $70.37M
YoY Change -57.13% -51.4% -36.23%
Depreciation, Depletion And Amortization $28.53M $28.75M $116.7M
YoY Change -3.4% -2.96% 5.14%
Cash From Operating Activities $45.72M $38.08M $164.4M
YoY Change -7.13% -32.33% -25.11%
INVESTING ACTIVITIES
Capital Expenditures $30.28M $64.96M $240.6M
YoY Change -31.89% 16.58% 36.2%
Acquisitions
YoY Change
Other Investing Activities $49.00K $16.92M $45.00K
YoY Change 8.89% 28.39% 18.42%
Cash From Investing Activities -$20.25M -$48.04M -$172.5M
YoY Change -28.4% 12.92% 27.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$4.956M -4.825M -$19.23M
YoY Change -5.85% 4.48% -68.45%
NET CHANGE
Cash From Operating Activities $45.72M 38.08M $164.4M
Cash From Investing Activities -$20.25M -48.04M -$172.5M
Cash From Financing Activities -$4.956M -4.825M -$19.23M
Net Change In Cash $20.52M -14.79M -$27.39M
YoY Change 30.78% -262.35% -216.02%
FREE CASH FLOW
Cash From Operating Activities $45.72M $38.08M $164.4M
Capital Expenditures $30.28M $64.96M $240.6M
Free Cash Flow $15.44M -$26.88M -$76.18M
YoY Change 223.8% -4987.09% -277.71%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
35019000 usd
CY2022 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
38079000 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
1120534000 usd
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
81312168
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
81115132
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
757386000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
990339000 usd
CY2023 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1131455000 usd
CY2022 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1263878000 usd
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
973644000 usd
CY2023 us-gaap Labor And Related Expense
LaborAndRelatedExpense
378818000 usd
CY2022 us-gaap Labor And Related Expense
LaborAndRelatedExpense
390304000 usd
CY2021 us-gaap Labor And Related Expense
LaborAndRelatedExpense
317962000 usd
CY2022 mrtn Purchased Transportation
PurchasedTransportation
249792000 usd
CY2021 mrtn Purchased Transportation
PurchasedTransportation
193221000 usd
CY2021 mrtn Fuel And Fuel Tax Expense
FuelAndFuelTaxExpense
131288000 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Small Business
EntitySmallBusiness
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2023Q4 us-gaap Assets
Assets
990339000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
36516000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
37299000 usd
CY2023Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
47017000 usd
CY2022Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
45747000 usd
CY2023Q4 mrtn Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
26709000 usd
CY2022Q4 mrtn Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
41264000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
110242000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
124310000 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
122462000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
137041000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
249000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
409000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
232953000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
261760000 usd
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
81312168
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
813000 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
49789000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
706784000 usd
CY2023 mrtn Purchased Transportation
PurchasedTransportation
199334000 usd
CY2023 mrtn Fuel And Fuel Tax Expense
FuelAndFuelTaxExpense
180437000 usd
CY2023 mrtn Supplies And Maintenance Expense
SuppliesAndMaintenanceExpense
67411000 usd
CY2022 mrtn Supplies And Maintenance Expense
SuppliesAndMaintenanceExpense
55700000 usd
CY2023 us-gaap Depreciation
Depreciation
116722000 usd
CY2022 us-gaap Depreciation
Depreciation
111014000 usd
CY2023 us-gaap Taxes And Licenses
TaxesAndLicenses
11053000 usd
CY2022 us-gaap Taxes And Licenses
TaxesAndLicenses
10763000 usd
CY2023 us-gaap General Insurance Expense
GeneralInsuranceExpense
56014000 usd
CY2022 us-gaap General Insurance Expense
GeneralInsuranceExpense
50513000 usd
CY2023 mrtn Communications And Utilities Expense
CommunicationsAndUtilitiesExpense
10149000 usd
CY2022 mrtn Communications And Utilities Expense
CommunicationsAndUtilitiesExpense
9177000 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
26304000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
85428000 usd
CY2023 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
0
CY2023Q4 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
33200000 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
1041345000 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
861955000 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
143344000 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
111689000 usd
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
43000 usd
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0000799167
CY2023 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2022 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0 usd
CY2023 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0 usd
CY2023 mrtn Customer Contract Term
CustomerContractTerm
P1Y
CY2023 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
4 pure
CY2023 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
5 pure
CY2022Q3 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
0
CY2022Q4 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
0
CY2023 mrtn Loss On Deposits Above Fdic Amount
LossOnDepositsAboveFDICAmount
0 usd
CY2023 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
5 pure
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
1348378000 usd
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
81322168
CY2023 dei Auditor Name
AuditorName
GRANT THORNTON LLP
CY2023 dei Auditor Firm
AuditorFirmId
2014
CY2023 dei Auditor Location
AuditorLocation
Minneapolis, Minnesota
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
53213000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
80600000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
497000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
500000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
105501000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
120702000 usd
CY2023Q4 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
10356000 usd
CY2022Q4 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
7218000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
27512000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
27320000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
196582000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
235840000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
370103000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
346665000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
792233000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
728167000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1524000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1672000 usd
CY2022Q4 us-gaap Assets
Assets
965679000 usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
192000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
192000000
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
81115132
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
811000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
47188000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
655920000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
703919000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
965679000 usd
CY2022 mrtn Fuel And Fuel Tax Expense
FuelAndFuelTaxExpense
218571000 usd
CY2021 mrtn Supplies And Maintenance Expense
SuppliesAndMaintenanceExpense
45459000 usd
CY2021 us-gaap Depreciation
Depreciation
102562000 usd
CY2021 us-gaap Taxes And Licenses
TaxesAndLicenses
10534000 usd
CY2021 us-gaap General Insurance Expense
GeneralInsuranceExpense
41987000 usd
CY2021 mrtn Communications And Utilities Expense
CommunicationsAndUtilitiesExpense
8350000 usd
CY2021 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
26887000 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
90110000 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3806000 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
827000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
93916000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
144171000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
111732000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23543000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
33817000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
110354000 usd
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.03
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
620333000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
85428000 usd
CY2021 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
876000 usd
CY2021 mrtn Adjustments To Additional Paid In Capital Employee Taxes Paid In Exhange For Shares Witheld
AdjustmentsToAdditionalPaidInCapitalEmployeeTaxesPaidInExhangeForSharesWitheld
2743000 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2518000 usd
CY2021 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
54735000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
651677000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
110354000 usd
CY2022 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
41753000 usd
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
2000000 usd
CY2022 mrtn Adjustments To Additional Paid In Capital Employee Taxes Paid In Exhange For Shares Witheld
AdjustmentsToAdditionalPaidInCapitalEmployeeTaxesPaidInExhangeForSharesWitheld
1610000 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2814000 usd
CY2022 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
19563000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
703919000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
70373000 usd
CY2023 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
1210000 usd
CY2023 mrtn Adjustments To Additional Paid In Capital Employee Taxes Paid In Exhange For Shares Witheld
AdjustmentsToAdditionalPaidInCapitalEmployeeTaxesPaidInExhangeForSharesWitheld
926000 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2319000 usd
CY2023 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
19509000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
757386000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
70373000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
110354000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
85428000 usd
CY2023 us-gaap Depreciation
Depreciation
116722000 usd
CY2022 us-gaap Depreciation
Depreciation
111014000 usd
CY2021 us-gaap Depreciation
Depreciation
102562000 usd
CY2023 mrtn Amortization Expense For Tires In Service
AmortizationExpenseForTiresInService
7172000 usd
CY2022 mrtn Amortization Expense For Tires In Service
AmortizationExpenseForTiresInService
6604000 usd
CY2021 mrtn Amortization Expense For Tires In Service
AmortizationExpenseForTiresInService
6433000 usd
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-14579000 usd
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
11878000 usd
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
4065000 usd
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2319000 usd
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2814000 usd
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2518000 usd
CY2023 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-12751000 usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
36978000 usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
23649000 usd
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
21719000 usd
CY2022 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
23547000 usd
CY2021 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
16745000 usd
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3939000 usd
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
8227000 usd
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5749000 usd
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3615000 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
11893000 usd
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-823000 usd
CY2023 us-gaap Increase Decrease In Insurance Liabilities
IncreaseDecreaseInInsuranceLiabilities
1270000 usd
CY2022 us-gaap Increase Decrease In Insurance Liabilities
IncreaseDecreaseInInsuranceLiabilities
3733000 usd
CY2021 us-gaap Increase Decrease In Insurance Liabilities
IncreaseDecreaseInInsuranceLiabilities
2419000 usd
CY2023 mrtn Increase Decrease In Accrued Other Current Liabilities
IncreaseDecreaseInAccruedOtherCurrentLiabilities
-10484000 usd
CY2022 mrtn Increase Decrease In Accrued Other Current Liabilities
IncreaseDecreaseInAccruedOtherCurrentLiabilities
6352000 usd
CY2021 mrtn Increase Decrease In Accrued Other Current Liabilities
IncreaseDecreaseInAccruedOtherCurrentLiabilities
7391000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
164378000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
219489000 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
171204000 usd
CY2023 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
45000 usd
CY2022 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
38000 usd
CY2021 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
37000 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-172540000 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-134958000 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-123734000 usd
CY2023 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
19509000 usd
CY2022 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
19563000 usd
CY2021 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
54735000 usd
CY2023 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
-0 usd
CY2022 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
41753000 usd
CY2021 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
-0 usd
CY2023 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1210000 usd
CY2021 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2743000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-60926000 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-56602000 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-27387000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
23605000 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-9132000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
56995000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
66127000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
53213000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
80600000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
56995000 usd
CY2023 mrtn Increase Decrease Capital Expenditures Incurred But Not Yet Paid
IncreaseDecreaseCapitalExpendituresIncurredButNotYetPaid
-1612000 usd
CY2022 mrtn Increase Decrease Capital Expenditures Incurred But Not Yet Paid
IncreaseDecreaseCapitalExpendituresIncurredButNotYetPaid
10470000 usd
CY2021 mrtn Increase Decrease Capital Expenditures Incurred But Not Yet Paid
IncreaseDecreaseCapitalExpendituresIncurredButNotYetPaid
-6187000 usd
CY2023 mrtn Operating Lease Assets And Liabilities Acquired
OperatingLeaseAssetsAndLiabilitiesAcquired
89000 usd
CY2022 mrtn Operating Lease Assets And Liabilities Acquired
OperatingLeaseAssetsAndLiabilitiesAcquired
318000 usd
CY2021 mrtn Operating Lease Assets And Liabilities Acquired
OperatingLeaseAssetsAndLiabilitiesAcquired
0 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
10000 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
65000 usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
497000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
500000 usd
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
22239000 usd
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-13526000 usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
9795000 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<b>Use of estimates:</b> We must make estimates and assumptions to prepare the consolidated financial statements in conformity with U.S. generally accepted accounting principles. These estimates and assumptions affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities in the consolidated financial statements and the reported amount of revenue and expenses during the reporting period. These estimates are primarily related to insurance and claims accruals and depreciation. Ultimate results could differ from these estimates.
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
4608000 usd
CY2022Q4 us-gaap Prepaid Insurance
PrepaidInsurance
4054000 usd
CY2023Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
2106000 usd
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
2746000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
3971000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
3734000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
27512000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
27320000 usd
CY2023Q4 mrtn Accrued Expenses
AccruedExpenses
10575000 usd
CY2022Q4 mrtn Accrued Expenses
AccruedExpenses
14426000 usd
CY2023Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
9612000 usd
CY2022Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
9776000 usd
CY2023Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
3800000 usd
CY2022Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
14750000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2722000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2312000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
26709000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
41264000 usd
CY2023Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
30000000 usd
CY2023Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
20700000 usd
CY2023Q4 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
9300000 usd
CY2022Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
16100000 usd
CY2022Q4 mrtn Line Of Credit Facility Dividends Payment Maximum
LineOfCreditFacilityDividendsPaymentMaximum
150000000 usd
CY2022Q4 mrtn Line Of Credit Facility Dividend Restrictions Percentage Of Net Income Limit
LineOfCreditFacilityDividendRestrictionsPercentageOfNetIncomeLimit
0.25 pure
CY2022Q4 mrtn Line Of Credit Facility Dividend Restrictions Percentage Of Net Income Limit1
LineOfCreditFacilityDividendRestrictionsPercentageOfNetIncomeLimit1
0.25 pure
CY2022Q4 mrtn Line Of Credit Facility Waiver To Pay Dividends Maximum
LineOfCreditFacilityWaiverToPayDividendsMaximum
80000000 usd
CY2021Q4 mrtn Line Of Credit Facility Waiver To Pay Dividends Maximum
LineOfCreditFacilityWaiverToPayDividendsMaximum
80000000 usd
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
33416000 usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
18025000 usd
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
18872000 usd
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
4706000 usd
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
3914000 usd
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
3367000 usd
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
38122000 usd
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
21939000 usd
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
3462000 usd
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-1053000 usd
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
2083000 usd
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
603000 usd
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-14579000 usd
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
11878000 usd
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
4065000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23543000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
33817000 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
26304000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.03 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.03 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.03 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.02 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
-0.01 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
-0.01 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
0 pure
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.25 pure
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.23 pure
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.24 pure
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
13126000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
13244000 usd
CY2023Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1212000 usd
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1597000 usd
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
14338000 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
14841000 usd
CY2023Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
133634000 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
148285000 usd
CY2023Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
3166000 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
3597000 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
136800000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
151882000 usd
CY2023Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
122462000 usd
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
137041000 usd
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
434000 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
438000 usd
CY2023 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
4000 usd
CY2023Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
343000 usd
CY2023 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
14000 usd
CY2022 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
10000 usd
CY2023 us-gaap Open Tax Year
OpenTaxYear
2020
CY2023 us-gaap Net Income Loss
NetIncomeLoss
70373000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
110354000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
85428000 usd
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
81272000
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
81692000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
82872000
CY2023 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
141000
CY2022 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
267000
CY2021 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
536000
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
81413000
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
81959000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
83408000
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.87
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.35
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.03
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.86
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.35
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.02
CY2019Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
34000000 usd
CY2019Q3 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
1800000
CY2020Q3 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
2700000
CY2022Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
50000000 usd
CY2022Q2 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
3100000
CY2022Q1 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
1300000
CY2022Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
25000000 usd
CY2022Q2 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
963000
CY2022Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
16800000 usd
CY2023Q4 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
2200000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
296000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
125000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
64000 usd
CY2023Q4 mrtn Lessee Operating Lease Liability Payments Due Year Four And Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFourAndFive
76000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
561000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
44000 usd
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P33M
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P39M
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.051 pure
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.044 pure
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
89000 usd
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
318000 usd
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
332000 usd
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
285000 usd
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
6500000 usd
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
5700000 usd
CY2023 us-gaap Short Term Lease Cost
ShortTermLeaseCost
6200000 usd
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
5400000 usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
2674431
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.28 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.26 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.27 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.041 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.029 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.012 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0114 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0113 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0091 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.63
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.79
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.29
CY2023 mrtn Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeiture Rate Of Unvested Outstanding Awards
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRateOfUnvestedOutstandingAwards
0.0125 pure
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2300000 usd
CY2023 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
1700000 usd
CY2023 mrtn Share Based Compensation Expense Net Of Tax Amount Per Basic Share
ShareBasedCompensationExpenseNetOfTaxAmountPerBasicShare
0.02
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2800000 usd
CY2022 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
2200000 usd
CY2022 mrtn Share Based Compensation Expense Net Of Tax Amount Per Basic Share
ShareBasedCompensationExpenseNetOfTaxAmountPerBasicShare
0.03
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2500000 usd
CY2021 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
1900000 usd
CY2021 mrtn Share Based Compensation Expense Net Of Tax Amount Per Basic Share
ShareBasedCompensationExpenseNetOfTaxAmountPerBasicShare
0.02
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
915391
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
15.84
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
39000
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
21.44
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
106941
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
11.3
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
9300
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
18.35
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
838150
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
16.65
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
431850
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
15.12
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
838150
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y10M24D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3800000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
431850
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y10M24D
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
2600000 usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1100000 usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
2000000 usd
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
789000 usd
CY2023 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2400000 usd
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4000000 usd
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1700000 usd
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
744000 usd
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
691000 usd
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
411000 usd
CY2023 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.35 pure
CY2023 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.06 pure
CY2023 us-gaap Defined Contribution Plan Employers Matching Contribution Annual Vesting Percentage
DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage
0.20 pure
CY2023 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
3900000 usd
CY2022 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
4000000 usd
CY2021 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
3000000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
561000 usd
CY2023 us-gaap Revenues
Revenues
1131455000 usd
CY2022 us-gaap Revenues
Revenues
1263878000 usd
CY2021 us-gaap Revenues
Revenues
973644000 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
90110000 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
143344000 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
111689000 usd

Files In Submission

Name View Source Status
0001437749-24-005794-index-headers.html Edgar Link pending
0001437749-24-005794-index.html Edgar Link pending
0001437749-24-005794.txt Edgar Link pending
0001437749-24-005794-xbrl.zip Edgar Link pending
ex_627040.htm Edgar Link pending
ex_627041.htm Edgar Link pending
ex_627042.htm Edgar Link pending
ex_627044.htm Edgar Link pending
ex_627045.htm Edgar Link pending
ex_627046.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g01.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
mrtn-20231231.xsd Edgar Link pending
mrtn20231231_10k.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
mrtn-20231231_def.xml Edgar Link unprocessable
mrtn-20231231_lab.xml Edgar Link unprocessable
mrtn-20231231_pre.xml Edgar Link unprocessable
mrtn20231231_10k_htm.xml Edgar Link completed
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
mrtn-20231231_cal.xml Edgar Link unprocessable